The BPSC: A prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population

Abstract

Bladder cancer and benign prostatic hyperplasia have been two very common diseases among the elderly men, especially with the aging of the population in the world. We have designed a study to investigate the clinical effect of interventional therapy for plasmakinetic resection of the prostate and plasmakinetic resection of the bladder, which is called "BPSC" (The bladder cancer and benign prostatic hyperplasia study in Chinese population). The BPSC is not only a specific study, it is made up of many studies. In this article, we introduced the research background, source, name, study framework, study management and further direction of BPSC project. We hope this process will contribute to the growth of the database through sharing data and enriching the evidence of bladder cancer and benign prostatic hyperplasia in the Chinese population, thereby finally improving the accessibility of these important findings for doctors, researchers, and patients.

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients

“…The study subjects were selected from the Bladder Cancer and Benign Prostatic Hyperplasia Study in Chinese Population (BPSC), which was a prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and BPH ( Zeng et al, 2018 ). This research was reviewed and approved by the Committee for Ethical Affairs of the Zhongnan Hospital of Wuhan University at Wuhan City, Hubei Province (Approval No.…”

Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients

“…The study subjects were selected from the Bladder Cancer and Benign Prostatic Hyperplasia Study in Chinese Population (BPSC), which was described previously [28–30]. As of January 2018, 771 BPH patients were enrolled in the BPSC database.…”

Role of CYP17 rs743572 Polymorphism in Benign Prostatic Hyperplasia: A Multivariate Integrated Analysis

“…BPH alone is rarely a fatal condition but can decrease the quality of life. More and more researchers have indicated that BPH may be a new metabolic disease of aging males (Corona et al, 2014; De Nunzio et al, 2014; Vignozzi et al, 2014; Gacci et al, 2015; Li et al, 2018; Shih et al, 2018; Zeng et al, 2018a,b,c). In addition, BPH is a multifactorial and complex disease and its etiology remains unclear.…”

“…In addition, BPH is a multifactorial and complex disease and its etiology remains unclear. Hence, the need to identify the etiology or risk factors of BPH is urgent and our team has proposed a study protocol to identify the risk factors for BPH (Zeng et al, 2018a).…”